FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Israel Hanin

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Israel Hanin; Manfred Windisch; Werner Poewe; Abraham Fisher
The 8th International Conference on Alzheimer's and Parkinson's Diseases. Preface.
Qing Ma; Umberto Cornelli; Israel Hanin; Walter P Jeske; Robert J Linhardt; Jeanine M Walenga; Jawed Fareed; John Lee
Heparin oligosaccharides as potential therapeutic agents in senile dementia.
Qing Ma; Mahmut Tobu; Christopher Schultz; Walter P Jeske; Debra Hoppensteadt; Jeanine M Walenga; Umberto Cornelli; John Lee; Robert J Linhardt; Israel Hanin; Jawed Fareed
Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Israel Hanin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Israel Hanin; Manfred Windisch; Werner Poewe; Abraham Fisher
The 8th International Conference on Alzheimer's and Parkinson's Diseases. Preface.
Neuro-degenerative diseases 2008;5(3-4):113.
2007: Qing Ma; Umberto Cornelli; Israel Hanin; Walter P Jeske; Robert J Linhardt; Jeanine M Walenga; Jawed Fareed; John Lee
Heparin oligosaccharides as potential therapeutic agents in senile dementia.
Current pharmaceutical design 2007;13(15):1607-16.
2007: Qing Ma; Mahmut Tobu; Christopher Schultz; Walter P Jeske; Debra Hoppensteadt; Jeanine M Walenga; Umberto Cornelli; John Lee; Robert J Linhardt; Israel Hanin; Jawed Fareed
Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.
Thrombosis research 2007;119(5):653-61.
2005: K Semeniken; Israel Hanin; Bertalan Dudas
Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.
Brain research 2005;1049(2):240-3.
2005: Bertalan Dudas; Michael Rose; Umberto Cornelli; Israel Hanin
Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Brain research 2005;1033(1):34-40.
2004: Michael Rose; Bertalan Dudas; Umberto Cornelli; Israel Hanin
Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Brain research 2004;1015(1-2):96-102.
2004: Bertalan Dudas; Israel Hanin; Michael Rose; Ernst Wülfert
Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Neurobiology of disease 2004;15(2):262-8.
2003: Michael Rose; Bertalan Dudas; Umberto Cornelli; Israel Hanin
Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.
Neurobiology of aging 2003;24(3):481-90.
2003: Bertalan Dudas; Michael Rose; Israel Hanin
Dose-dependent effect of cholinotoxin AF64A on the cholinergic elements of the cingulum bundle in rat.
Brain research 2003;965(1-2):295-8.
2003: Qing Ma; Christopher Schultz; Brian Neville; Walter P Jeske; Debra Hoppensteadt; Umberto Cornelli; John Lee; Stanley Lorens; Israel Hanin; Jawed Fareed
Pharmacodynamics and pharmacokinetics of C3, a heparin-derived oligosaccharide mixture, in non-human primates.
Thrombosis research 2003;112(4):249-55.
2002: Mark Walzer; Stanley Lorens; Matthew J Hejna; Jawed Fareed; Israel Hanin; Umberto Cornelli; John Lee
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology.
European journal of pharmacology 2002;445(3):211-20.
2002: Qing Ma; Bertalan Dudas; Matthew J Hejna; Umberto Cornelli; John Lee; Stanley Lorens; Ronald Mervis; Israel Hanin; Jawed Fareed
The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3.
Thrombosis research 2002;105(5):447-53.
2002: Qing Ma; Bertalan Dudas; Asif Daud; Omer Iqbal; Debra Hoppensteadt; Walter P Jeske; Umberto Cornelli; John Lee; Stanley Lorens; Ronald Mervis; Israel Hanin; Ishan Capila; Robert J Linhardt; Jawed Fareed
Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.
Thrombosis research 2002;105(4):303-9.
2002: Bertalan Dudas; Umberto Cornelli; John Lee; Matthew J Hejna; Mark Walzer; Stanley Lorens; Ronald Mervis; J Fareed; Israel Hanin
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Neurobiology of aging 2002;23(1):97-104.
2000: Bertalan Dudás; A Mihaly; Israel Hanin
A ventral approach to stereotaxy of the guinea pig brain.
Journal of neuroscience methods 2000;99(1-2):79-83.
1999: Q I Fan; Israel Hanin
Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.
Neurochemical research 1999;24(1):15-24.
1998: X Zhang; GH Kindel; Ernst Wülfert; Israel Hanin
Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats.
Acta anaesthesiologica Scandinavica 1998;42(8):1004-9.
1998: L R Santiago; L C Erickson; Israel Hanin
AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3.
Neurochemical research 1998;23(5):743-50.
1998: M R Pranzatelli; Israel Hanin; Elizabeth D Tate; GH Kindel; A Bergin; C M Brown; P Habersang; R Habersang; K J Mack; B Rosenbaum; K A Selby; M Vasconcellos
Cerebrospinal fluid free choline in movement disorders of paediatric onset.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 1998;2(1):33-9.
1997: S Y Kim; K Raikoff; Ernst Wülfert; Israel Hanin
Bradycardia induced by mivazerol, a selective alpha 2-adrenoceptor agonist, is amplified during mild hypothermia in the pentobarbital-anesthetized rat.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(6):751-5.
1997: C A Willson; Israel Hanin
Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats.
Neuroscience letters 1997;229(3):149-52.
1997: X Zhang; Ernst Wülfert; Israel Hanin
Mivazerol, a new alpha 2-adrenergic agonist, blunts cardiovascular effects following surgical stress in pentobarbital-anesthetized rats.
Acta anaesthesiologica Scandinavica 1997;41(6):694-700.
1996: S Y Kim; K Raikoff; Ernst Wülfert; Israel Hanin
Mivazerol, a selective alpha 2-adrenoceptor agonist, attenuates tachycardia by intrathecal injection of N-methyl-D-aspartate in the rat.
European journal of pharmacology 1996;316(2-3):249-52.
1996: A El Tamer; I Prokopenko; Ernst Wülfert; Israel Hanin
Mivazerol, a novel alpha2-agonist and potential anti-ischemic drug, inhibits KC1-stimulated neurotransmitter release in rat nervous tissue preparations.
Journal of neurochemistry 1996;67(2):636-44.
1996: A El Tamer; Ernst Wülfert; Israel Hanin
Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
Neuroscience letters 1996;203(2):123-6.
1996: Israel Hanin
The AF64A model of cholinergic hypofunction: an update.
Life sciences 1996;58(22):1955-64.
1995: X Zhang; G H Kindel; Ernst Wülfert; Israel Hanin
Effects of immobilization stress on hippocampal monoamine release: modification by mivazerol, a new alpha 2-adrenoceptor agonist.
Neuropharmacology 1995;34(12):1661-72.
1995: L R Santiago; M T Ivy; L C Erickson; Israel Hanin
AF64A-induced cytotoxicity and changes in choline acetyltransferase activity in the LA-N-2 neuroblastoma cell line are modulated by choline and hemicholinium-3.
Journal of neuroscience methods 1995;61(1-2):185-90.
1995: C A Willson; Israel Hanin
Effect of nerve growth factor in ethylcholine mustard aziridinium (AF64A)-treated rats: sensitization of cholinergic enzyme activity in the septohippocampal pathway.
Journal of neurochemistry 1995;65(2):856-62.
1995: James J Chrobak; Israel Hanin; Stanley Lorens; T Celeste Napier
Within-subject decline in delayed-non-match-to-sample radial arm maze performance in aging Sprague-Dawley rats.
Behavioral neuroscience 1995;109(2):241-5.
1995: C A Willson; Johan Luthman; Barry Hoffer; Israel Hanin
The use of the rat iris as a model system to evaluate the effect of the cholinotoxin, AF64A, in vivo.
Journal of neuroscience methods 1995;56(1):49-55.
1994: D Amoroso; G Kindel; Ernst Wülfert; Israel Hanin
Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
Brain research 1994;661(1-2):9-18.
1994: X W Dong; Israel Hanin; Stanley Lorens
AF64A affects septal choline acetyltransferase but not parvalbumin immunoreactive cells.
Brain research bulletin 1994;35(3):217-20.
1993: A el Tamer; K Raikoff; J Corey; Ernst Wülfert; Israel Hanin
ucb 11056, a new potential nootropic drug, amplifies induced cyclic AMP formation in rat brain tissue.
Journal of neurochemistry 1993;61(6):2256-61.
1993: Israel Hanin; X C Tang; G L Kindel; Alan P Kozikowski
Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo.
Annals of the New York Academy of Sciences 1993;695():304-6.
1993: K Elrod; K Raikoff; E Wulfert; Israel Hanin
UCB 29120, a novel, potential psychotropic agent, alters norepinephrine and dopamine content of rat brain.
Neuropharmacology 1993;32(6):535-42.
1993: Israel Hanin
Clinical aspects of cholinergic pharmacology.
Progress in brain research 1993;98():421-2.
1993: H Hörtnagl; L Hansen; G Kindel; B Schneider; A el Tamer; Israel Hanin
Sex differences and estrous cycle-variations in the AF64A-induced cholinergic deficit in the rat hippocampus.
Brain research bulletin 1993;31(1-2):129-34.
1992: Israel Hanin
Cholinergic toxins and Alzheimer's disease.
Annals of the New York Academy of Sciences 1992;648():63-70.
1992: Bernard W Futscher; R O Pieper; D M Barnes; Israel Hanin; L C Erickson
DNA-damaging and transcription-terminating lesions induced by AF64A in vitro.
Journal of neurochemistry 1992;58(4):1504-9.
1992: A el Tamer; J Corey; Ernst Wülfert; Israel Hanin
Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
Neuropharmacology 1992;31(4):397-402.
1992: X Zhang; E Wulfert; Israel Hanin
Development of a sensitive and inexpensive micropush-pull technique for the continuous analysis of brain neurotransmitters and metabolites in vivo.
Journal of neuroscience methods 1992;42(1-2):139-47.
1991: S Laganière; J Corey; X C Tang; Ernst Wülfert; Israel Hanin
Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.
Neuropharmacology 1991;30(7):763-8.
1991: Stanley Lorens; G Kindel; X W Dong; John Lee; Israel Hanin
Septal choline acetyltransferase immunoreactive neurons: dose-dependent effects of AF64A.
Brain research bulletin 1991;26(6):965-71.
1991: James J Chrobak; T Celeste Napier; Israel Hanin; T J Walsh
The pharmacology of basal forebrain involvement in cognition.
Advances in experimental medicine and biology 1991;295():383-98.
1990: S Laganiere; M Marinko; J Corey; E Wulfert; Israel Hanin
Sector-dependent neurotoxicity of ethylcholine aziridinium (AF64A) in the rat hippocampus.
Neuropharmacology 1990;29(10):961-4.
1990: Israel Hanin
AF64A-induced cholinergic hypofunction.
Progress in brain research 1990;84():289-99.
1989: P E Potter; C E Tedford; G Kindel; Israel Hanin
Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
Brain research 1989;487(2):238-44.
1989: H Hörtnagl; P E Potter; E A Singer; G Kindel; Israel Hanin
Clonidine prevents transient loss of noradrenaline in response to cholinergic hypofunction induced by ethylcholine aziridinium (AF64A).
Journal of neurochemistry 1989;52(3):853-8.
1989: H Hörtnagl; P E Potter; G Kindel; Israel Hanin
Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage.
Journal of neuroscience methods 1989;27(2):103-8.
1988: H Hörtnagl; P E Potter; K Happe; S Goldstein; S Leventer; E Wulfert; Israel Hanin
Role of the aziridinium moiety in the in vivo cholinotoxicity of ethylcholine aziridinium ion (AF64A).
Journal of neuroscience methods 1988;23(2):107-13.
1987: H Hörtnagl; P E Potter; Israel Hanin
Effect of cholinergic deficit induced by ethylcholine aziridinium (AF64A) on noradrenergic and dopaminergic parameters in rat brain.
Brain research 1987;421(1-2):75-84.
1987: H Hörtnagl; P E Potter; Israel Hanin
Effect of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain.
Neuroscience 1987;22(1):203-13.
1987: S M Leventer; E Wulfert; Israel Hanin
Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Neuropharmacology 1987;26(4):361-5.
1985: S Leventer; D McKeag; M Clancy; E Wulfert; Israel Hanin
Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices.
Neuropharmacology 1985;24(5):453-9.